Human Papillomavirus Infection
📧 Sign up to get email alerts when something new happens for Human Papillomavirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine [EARLY_Phase 1]
Phase 1 trial update evaluating whether a patient education/messaging platform increases uptake and completion of the HPV vaccine.
-
CLINICAL_TRIALS trial_result · 2016-05-25Clinical Trial Update: HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3 [NA]
A completed clinical trial evaluating reminder prompts to improve completion of HPV vaccine doses 2 and 3 is reported; no study results are …
-
CLINICAL_TRIALS research · 2016-05-25Clinical Trial Update: Human Papilloma Viruses (HPV) Vaccine Adherence Community Clinic Study [NA]
A completed clinical trial study evaluating adherence to the human papillomavirus vaccine in a community clinic, sponsored by East Carolina …
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: A New Supplement for the Immune Response to HPV Infection [NA]
A completed clinical trial evaluating a supplement intended to boost the immune response to human papillomavirus infection.
-
CLINICAL_TRIALS trial_result · 2016-05-17Clinical Trial Update: Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
This clinical trial investigated the natural history of HPV infection as it progresses to cervical neoplasia in adolescents and young women.…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010) [Phase 3]
Phase III trial update for a two-dose multivalent HPV vaccine (V503) in 9-14 year-olds compared to 16-26 year-olds; completed with results p…
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
Completed retrospective chart review evaluating the antiviral supplement Gene-Eden-VIR/Novirin across multiple viral infections to assess ou…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females [Phase 3]
Phase 3 trial comparing HPV vaccines under alternative 2-dose schedules in 9-14 year-old females, focusing on immunogenicity and safety; com…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Screening for HIV-Associated Anal Cancer
This clinical trial update indicates the study on screening for HIV-associated anal cancer has completed.
-
CLINICAL_TRIALS research · 2016-02-04Clinical Trial Update: HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts [NA]
A completed clinical trial investigating whether physician reminders and recommendation scripts improve HPV vaccination uptake; results were…
-
CLINICAL_TRIALS research · 2016-01-21Clinical Trial Update: Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men
Clinical trial update examining viral load and biomarkers for high-risk HPV types in HIV-positive men.
-
CLINICAL_TRIALS research · 2016-01-21Clinical Trial Update: Oral Human Papillomavirus Infection in HIV-infected Men
Clinical trial update concerning oral Human Papillomavirus infection in HIV-infected men.
-
CLINICAL_TRIALS research · 2015-12-10Clinical Trial Update: GARDASIL™ Vaccine Impact in Population Study (V501-033)
Clinical trial update on GARDASIL vaccine impact in a population study (NCT01077856) completed with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-11-26Clinical Trial Update: Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) [Phase 2]
Phase 2 study of a broad-spectrum HPV vaccine (V505-001) in women aged 16-26 has completed; the trial evaluated the vaccine's potential to p…
-
CLINICAL_TRIALS research · 2015-11-24Clinical Trial Update: HPV Screening (Human Papilloma Virus)
Clinical trial update for a Kasr El Aini Hospital HPV screening study (NCT02613611) focusing on HPV testing; current status is unknown.
-
CLINICAL_TRIALS research · 2015-11-02Clinical Trial Update: Yallaferon in Chinese Population [Phase 2]
Phase 2 clinical trial of Yallaferon for human papillomavirus infection in a Chinese population; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
This update reports on a completed clinical trial evaluating vaccination against human papillomavirus in survivors of childhood cancer.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Safety Evaluation of a Human Papillomavirus (HPV) Vaccine in Healthy Female Control Subjects From the GSK HPV 023 Study [Phase 3]
Phase 3 safety evaluation update from the GSK HPV 023 study showing safety results for an HPV vaccine in healthy female control subjects; re…
-
CLINICAL_TRIALS trial_result · 2015-08-13Clinical Trial Update: GARDASIL™ Post Marketing Surveillance in the Philippines (V501-077)
Gardasil post-marketing surveillance in the Philippines has been terminated. The study was sponsored by Merck Sharp & Dohme LLC.
-
CLINICAL_TRIALS trial_result · 2015-08-11Clinical Trial Update: Prevalence and Type Distribution of Human Papillomavirus (HPV) in Tanzanian Men
A completed clinical trial sponsored by the Danish Cancer Society evaluating the prevalence of HPV infection and the distribution of HPV typ…
-
CLINICAL_TRIALS withdrawal · 2015-07-20Clinical Trial Update: Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study [Phase 3]
A Phase 3 study evaluating long-term antibody persistence of GlaxoSmithKline's HPV-16/18 L1 VLP AS04 vaccine (GSK-580299) in healthy adults …
-
CLINICAL_TRIALS withdrawal · 2015-07-20Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years [Phase 3]
Phase 3 immunogenicity and safety study evaluating co-administration of Cervarix with Havrix in healthy girls aged 9-14, which has been with…
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Immunevasion of Human Papillomavirus (HPV) in Vulvar Intraepithelial Neoplasia 2/3 and Anogenital Warts and Efficiency and Mechanisms of Imiquimod Treatment [Phase 2]
Phase 2 clinical trial evaluating imiquimod for HPV-related vulvar intraepithelial neoplasia (VIN 2/3) and anogenital warts has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001)(COMPLETED) [Phase 2]
Completed Phase 2 trial evaluating tolerability and immunogenicity of the V504 HPV vaccine candidate when administered with GARDASIL for HPV…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001) [Phase 2]
Phase 2 dose-ranging study of Broad Spectrum HPV Vaccine (V502-001) completed; the trial evaluated the vaccine across HPV-related conditions…